• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, September 16, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Immunology

One-year kidney allograft outcomes do not differ by hepatitis C status of donor

Bioengineer by Bioengineer
December 14, 2020
in Immunology
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: AJKD, 2020

Study published in the American Journal of Kidney Diseases (AJKD) shows that kidney allograft outcomes one year post-transplantation in hepatitis C virus (HCV)-negative recipients do not differ by the HCV status of the donor.

Transplant centers are increasingly willing to transplant kidneys from hepatitis C (HCV)-infected donors to HCV-negative recipients. Data on the long-term outcomes following these recipients are sparse. The aim of this single-center, retrospective study was to compare 1-year kidney outcomes in HCV-negative transplant recipients who received an organ either from a donor with or without HCV infection. The 1-year post-transplant kidney outcomes (including allograft function, development of de novo donor specific antibodies, findings on for-cause and surveillance protocol graft biopsies) were similar in these two groups of recipients.

###

ARTICLE TITLE: Transplantation of Kidneys From Hepatitis C Virus-Infected Donors to Hepatitis C Virus-Negative Recipients: One-Year Kidney Allograft Outcomes

AUTHORS: Miklos Z. Molnar, MD, PhD, Ambreen Azhar, MD, Makoto Tsujita, MD, PhD, Manish Talwar, MD, Vasanthi Balaraman, MD, Anshul Bhalla, MD, Pradeep S.B. Podila, PhD, MS, Jiten Kothadia, MD, Uchenna A. Agbim, MD, MPH, Benedict Maliakkal, MD, Sanjaya K. Satapathy, MD, MS, Csaba P Kovesdy, MD, Satheesh Nair, MD, and James D. Eason, MD

DOI: 10.1053/j.ajkd.2020.10.017

Full text of article available by email from media contact.

Media Contact
Julie Kimbrough
[email protected]

Related Journal Article

http://dx.doi.org/10.1053/j.ajkd.2020.10.017

Tags: EpidemiologyHealth CareHealth Care Systems/ServicesHealth ProfessionalsInfectious/Emerging DiseasesInternal MedicineMedicine/HealthPublic HealthSurgeryTransplantation
Share12Tweet8Share2ShareShareShare2

Related Posts

IMAGE

UMass Amherst grad student awarded fellowship for food allergy research

July 23, 2021
IMAGE

Less-sensitive COVID-19 tests may still achieve optimal results if enough people tested

July 22, 2021

Public trust in CDC, FDA, and Fauci holds steady, survey shows

July 20, 2021

USC study shows male-female differences in immune cell function

July 19, 2021
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    154 shares
    Share 62 Tweet 39
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    66 shares
    Share 26 Tweet 17
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Shifts in Infective Endocarditis Demographics: 2012-2021

Assessing Disability: WHO vs. Daily Living Scales

Creating a Sulfur Vacancy Redox Disruptor for Innovative Therapies Targeting Cuproptosis, Ferroptosis, and Apoptosis through Photothermoelectric and Cascade Catalytic Mechanisms

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.